gary breca bpc 157 BPC 157 💉 . It's not a steroid, it's a peptide 🧬 . Potential benefits Gary Brecka: Human Biologist on

It bypasses first-pass hepatic metabolism which oral delivery does not allowing a greater proportion of the absorbed peptide to remain intact as it enters circulation.7 The olfactory pathway also provides a potential direct nose-to-brain route, bypassing the blood-brain barrier a property that has generated interest for neuropeptides and potential neurological applications

The FDA decision on BPC-157 The FDA placed BPC-157 on its list of Category 2 bulk drug substances

Advanced protocol Experienced researchers sometimes use higher doses, though diminishing returns and increased side effect risk apply

Safety and Regulatory Differences Both BPC-157 and TB-500 carry similar broad regulatory characterizations - neither has FDA or EMA approval for human use, both are sold strictly as research chemicals for in vitro and animal-model investigation - but the specific regulatory facts differ